HSIC — —
Loading…
— —
PREV CLOSE — OPEN — DAY RANGE —
Analyzing 0%
MASTER — —
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—

HSIC Stock AI Analysis

ESEN AI analysis of HSIC stock updated every 12 hours.

ESEN Institutional Analysis

HSIC Systematic Research

Henry Schein Inc operates as a healthcare products distributor with systematic screening revealing distinctive margin compression despite revenue expansion. The company's net margin of 2.95% appears notably constrained for a distributor of this scale, while the operating margin of 4.93% reflects competitive intensity in dental and medical supply distribution channels. Revenue growth of 5.64% year-over-year demonstrates market share maintenance, though EPS growth of 2.93% lags top-line expansion, indicating margin pressure or elevated operational costs.

The valuation framework presents contrasting signals. The price-to-sales ratio of 0.73x positions below typical healthcare distributor multiples, while the P/E of 24.8x exceeds historical norms for low-margin distribution businesses. This disconnect between relative cheapness on revenue and premium pricing on earnings warrants analytical scrutiny. The ROE of 11.86% exceeds the cost of capital for most distributors, though remains modest compared to higher-value healthcare segments.

Balance sheet metrics reveal moderate leverage with debt-to-equity of 0.96x and adequate liquidity through a current ratio of 1.38x. The defensive characteristics manifest in a beta of 0.81, suggesting lower volatility than broader equity markets during periods of uncertainty.

  • Risk perspective: Thin operating margins leave limited buffer for input cost inflation or competitive pricing pressure
  • Risk consideration: The spread between revenue growth and earnings growth signals potential structural margin headwinds

Relative to distribution peers McKesson, Cardinal Health, and Cencora, fundamental screening indicates HSIC trades at compressed sales multiples but expanded earnings multiples, reflecting its concentrated exposure to dental markets with distinct cyclical characteristics.

Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.

Related Stocks
AAPL NVDA MSFT AMZN GOOGL META TSLA AVGO JPM V MA LLY UNH XOM JNJ WMT PG HD MRK COST BAC ABBV CRM CVX ORCL KO PEP AMD NFLX ADBE

Explore AI analysis for top stocks — Full Rankings · AI Screener · Earnings Calendar